1 / 3

Global Major Depressive Disorder (MDD) Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast Per

Major depressive disorder (MDD) also known as clinical depression is a mental health disorder which affects mood, behavior as well as appetite and sleep.

coherent
Download Presentation

Global Major Depressive Disorder (MDD) Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast Per

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Major Depressive Disorder (MDD) Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018- 2026 Major depressive disorder (MDD) also known as clinical depression is a mental health disorder which afects mood, behavior as well as appetite and sleep. The exact cause of MDD is not known, however, several factors which can increase its risk is combination of genes and stress that afects brain chemistry and reduce the ability to maintain mood stability. Imbalanced hormone, alcohol or drug abuse, certain medical conditions such as cancer or hypothyroidism, and some adverse efects of medication such as steroids can also lead to MDD. Changing lifestyles such as work pressure, alcohol abuse, and others has resulted in increasing prevalence of MDD, which is expected to drive market growth over the forecast period. For instance, according to an article published in National Center for Biotechnology Information 2015, MDD is the most common psychiatric disorder in India and the lifetime prevalence of MDD is 10–25% for women, and 5–12% for men. Download PDF Brochure of Market Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1217 Major Depressive Disorder (MDD) Treatment Market Taxonomy The major depressive disorder (MDD) treatment market is segmented on the basis of product type and geography On the basis of product type, major depressive disorder (MDD) treatment market is segmented into: •Drug Type •Antidepressants •Selective Serotonin Reuptake Inhibitors (SSRIS) •Lexapro (Escitalopram)

  2. •Viibryd (Vilazodone) •Dopamine Norepinephrine Reuptake Inhibitor •Serotonin Norepinephrine Reuptake Inhibitor •Cymbalta (Duloxetine) •Efexor (Venlafaxine) •Fetzima (Levomilnacipran) •Savella (Milnacipran) •Pristiq (Desvenlafaxine) •Serotonin Modulators •Norepinephrine-Serotonin Modulator •Tricyclics and Tetracyclics •Atypical Antidepressants •Antipsychotics •Abilify (Aripiprazole) •Seroquel XR (Quetiapine XR) •Rexulti (Brexpiprazole) •Neuromodulators •Stem Cell Therapy Browse more about the Deep Brain Stimulation Devices Market Study: https://www.coherentmarketinsights.com/insight/request-customization/1217 Market Players Eli Lilly and Company, Allergan, Alkermes, Lundbeck, Johnson & Johnson, Pfzer, Inc., AstraZeneca plc, Merck & Co., GlaxoSmithKline plc. Sanof S.A., and Takeda Pharmaceutical Company Limited. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

  3. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related